Home›Stocks›ALXO

ALXO — structural market context

ALX Oncology Holdings Inc.

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Oct 21. Each line shows the earlier value, the later value and their dates.

Price

Close $1.15 (Oct 21) vs $1.24 (Oct 20): −7.26%.

Volume

0.59× its 20-session average (1.6M) on Oct 21.

Includes pre- and post-market trading.

Short interest

Short interest 5.7M shares (settlement Sep 30) vs 6.3M (Sep 15).

No new publication in this window. Latest: settlement Sep 30, published Oct 10.

Fails-to-deliver

Latest file (settlements Sep 15–Sep 30, published Oct 16): 1 day with fails, largest 17 shares on Sep 17.

Previous file (settlements Sep 1–Sep 14, published Sep 30): 1 day with fails, largest 15K shares on Sep 2.

No new publication in this window.

Insider filings (Form 4)

None recorded in this window.

ALXO short interest & days to cover

SHARES SHORT
5.7M
% OF FLOAT
5.8%
DAYS TO COVER
3.8
CHANGE VS PRIOR
-9.6%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (22d ago)

ALXO fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-17 · 35d17$1.76
2026-09-02 · 50d15K$1.98
2026-08-21 · 62d39$1.99

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

ALXO insider buying and selling (Form 4)

Last 12 months, Form 4 codes P and S: 0 purchases · 2 sales

InsiderTypeSharesValueFiled
Lettmann Jason · director, officer: CHIEF EXECUTIVE OFFICERSale (S)2K$4K2026-08-18
Wong Shelly · officer: SVP, FINANCE AND CAOSale (S)573$1K2026-08-18

SEC Form 4 filings: purchases and sales reported on Form 4 (transaction codes P and S) only; grants and option exercises excluded. Attributed public records.

Frequently asked questions

What is ALXO's short interest?
As of the FINRA settlement date 2026-09-30, ALXO had 5.7M shares sold short — 5.8% of its float, with 3.8 days to cover at average volume. FINRA publishes this data roughly two weeks after each twice-monthly settlement, so it is inherently delayed. A short-interest figure describes an aggregate position; it does not predict what the stock will do.
Are insiders buying ALXO?
In the last 12 months of SEC Form 4 filings, ALXO recorded 0 insider purchases and 2 sales reported on Form 4 (transaction codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
Is this page telling me to buy or sell ALXO?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with A

AA · Alcoa CorporationAADX · Applied Aerospace & Defense, IAAPG · Ascentage Pharma Group InternaAAPL · Apple Inc.AAUC · Allied Gold CorporationAAVMY · ABN AMRO BK N V AMSTERDAM BRHAll A →

ALXO: the full history

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.